Levodropropizine

Drug #2329

Levodropropizine is a cough suppressant. It is the levo isomer of dropropizine. It acts as a peripheral antitussive, with no action in the central nervous system.

← Previous drug Next drug →

Primary Characteristics

It is of Synthetic origin.

It is classified in Cough pharmacological group.

Molecular Weight: 236 · Non-proprietary name: Levodropropizine.

Pharmacokinetics

Distribution: Levodropropizine has a plasma protein binding is 13%.

Elimination: plasma half-life is 1-2hrs, renal excretion is urine.

Indications

Levodropropizine is primarily indicated in conditions like Cough.

Contraindications

None recorded.

Dosage

Levodropropizine's dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
10 ml	10 ml	—	PO	with at least 6-hour-intervals
Paediatric Dosage (20kg)
0 – 3 ml	—	Every 8h		10-20kg
0 – 0	—	—		20-30kg
Neonatal Dosage (3kg)
No data.

Drug Interactions

1 interaction

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Levodropropizine is known to cause more or less tolerable side effects which are usually transient. These include Diarrhea, Dizziness, Drowsiness, Fatigue, Headache, Heart burn, Nausea, Palpitation, Vomiting , Weakness.

Warnings / Precautions

Caution should be exercised in patients with history of severe kidney insufficiency, any allergy, children, during pregnancy and breastfeeding. It may cause dizziness or drowsiness, do not drive a car or operate machinery while taking this medication.

Available Brands

None recorded.

Storage Conditions

Levodropropizine should be stored syrup.

Drug Classification

1.25.2.3 — Cough sedatives